SCHEMBL6587141

SCHEMBL6587141

CN(C)CCCC1c2ccccc2CN1c1ccncc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 7/20 0.50
HRH1 P35367 6/20 0.50
HTR2C P28335 4/20 0.41
CDK8 P49336 1/20 0.37
CDK5 Q00535 1/20 0.37
DRD2 P14416 3/20 0.36
ADRA1A P35348 3/20 0.36
DRD4 P21917 2/20 0.35
DRD3 P35462 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
CHRM2 P08172 2/20 0.35
CHRM4 P08173 2/20 0.35
CHRM5 P08912 2/20 0.35
CHRM1 P11229 2/20 0.35
CHRM3 P20309 2/20 0.35
CYP2D6 P10635 2/20 0.35
HTR3E A5X5Y0 1/20 0.35
SLC22A2 O15244 1/20 0.35
SLC22A1 O15245 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL8433463 0.90 HRH1 (0.42) HTR2AHRH1HTR2CLMNAALDH1A1
Maleic Acid SCHEMBL8433458 0.90 HRH1 (0.42) HTR2AHRH1HTR2CLMNAALDH1A1
SCHEMBL6592097 0.83 EED (0.38) HTR2AHRH1LMNAMAPTADRA2B
SCHEMBL8519604 0.82 EED (0.34) HTR2AHRH1LMNAMAPTKDM4E
SCHEMBL6587862 0.80 EED (0.40) HTR2AHRH1HTR2CDRD2ADRA1A
SCHEMBL6586680 0.76 OPRM1 (0.41) HTR2ALMNAMAPTOPRM1OPRK1
Maleic Acid SCHEMBL6589525 0.74 SLC6A2 (0.42) HTR2ALMNAALDH1A1HTR1ASLC6A2
Fumaric Acid SCHEMBL6589530 0.74 SLC6A2 (0.42) HTR2ALMNAALDH1A1HTR1ASLC6A2
SCHEMBL6591541 0.72 TIPARP (0.43) LMNAMAPTSLC6A2SLC6A4OPRM1
Fumaric Acid SCHEMBL6592830 0.71 SLC6A2 (0.39) HTR2ALMNAMAPTALDH1A1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0703232-B1 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors AVENTIS PHARMA INC (US) 2004-06-30 EP claimed
US-5567718-A PSYCHOLOGICAL DISORDERS HOECHST MARION ROUSSEL INC. (US) 1996-10-22 US claimed
EP-0703232-A2 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-03-27 EP claimed
EP-0703232-B1 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors AVENTIS PHARMA INC (US) 2004-06-30 EP disclosed
US-5874458-A PSYCHOLOGICAL DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-23 US disclosed
US-5869685-A SEROTONIN REUPTAKE INHIBITORS HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5567718-A PSYCHOLOGICAL DISORDERS HOECHST MARION ROUSSEL INC. (US) 1996-10-22 US disclosed
EP-0703232-A2 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-03-27 EP disclosed